Genmab | GEN - Ordinary Share Capital


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Genmab

Genmab reported DKK66M in Ordinary Share Capital for its fiscal quarter ending in March of 2023.


Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 72K 1000
Almirall ALM:SM 21.78M 0
Amarin AMRN:US USD 301.28M 2.28M
Artemis Alpha ATS:LN GBP 373K 0
AstraZeneca AZN:LN USD 387M 0
Bayer BAYN:GR EUR 2.52B 0
BioMarin Pharmaceutical BMRN:US USD 188K 2K
Bluebird Bio BLUE:US USD 1.06M 234K
Demant A/s WDH:DC DKK 46M 0
Exelixis EXEL:US USD 325K 1000
Galapagos GLPG:NA EUR 293.94M 333K
Genmab GEN:DC DKK 66M 0
GlaxoSmithKline GSK:LN GBP 1.35B 1000K
GN Store Nord GN:DC DKK 549M 0
Hikma Pharmaceutical HIK:LN USD 40M 1000K
Immunogen IMGN:US USD 2.26M 1000
Insmed INSM:US USD 1.36M 7K
Lonza Group LONN:SW CHF 74M 0
Merck MRK:GR EUR 565M 397M
Novartis NOVN:VX USD 842M 48M
Roche Holding ROG:VX 107M 0
Seattle Genetics SGEN:US USD 187K 0
UCB UCB:BB 584M 0